Landscapes / Companies
BioInvent International AB not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 in Phase 2
Drugs
4
in active trials · 6 in all
Trials
5 active
8 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 14 Jul 2027Phase 1/2 trial completes | |||
| Next date | 14 Jul 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumors, Non Small Cell Lung Cancer and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Sep 2027Phase 1/2 trial completes | |||
| Next date | 30 Sep 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Indolent B-Cell Non-Hodgkin Lymphoma | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Jan 2028Phase 1/2 trial completes | |||
| Next date | 31 Jan 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Malignancies, Ovarian Cancer and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Melanoma Metastatic, Melanoma of Skin and 8 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021